Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy
To compare the effectiveness of and adverse events related to intranodal glue embolization (IGE) with those of intracavitary sclerotherapy for the treatment of postoperative groin and pelvic lymphatic leaks. From November 2015 to July 2021, IGE for postoperative pelvic or groin lymphocele or lymphor...
Gespeichert in:
| Veröffentlicht in: | Journal of vascular and interventional radiology 2023-04, Vol.34 (4), p.600-606 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 606 |
|---|---|
| container_issue | 4 |
| container_start_page | 600 |
| container_title | Journal of vascular and interventional radiology |
| container_volume | 34 |
| creator | Seyferth, Elisabeth R. Itkin, Maxim Nadolski, Gregory J. |
| description | To compare the effectiveness of and adverse events related to intranodal glue embolization (IGE) with those of intracavitary sclerotherapy for the treatment of postoperative groin and pelvic lymphatic leaks.
From November 2015 to July 2021, IGE for postoperative pelvic or groin lymphocele or lymphorrhea was performed in 33 patients. From January 2010 to July 2021, 28 patients with postoperative pelvic or groin lymphocele were treated with sclerosis alone. Clinical success was defined as resolution of drainage within 3 weeks of the last intervention performed without recurrence. Patients presenting >1 year after surgery or with |
| doi_str_mv | 10.1016/j.jvir.2022.12.031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2758114761</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S105104432201435X</els_id><sourcerecordid>2758114761</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-e33b2c2f527641f8aa6a55a1d4ae394c0ff299053330e3fb63aa4c4618546f3c3</originalsourceid><addsrcrecordid>eNp9kMFqGzEQhkVpaNK0L9BD0bGX3UoaSWuXXopJnYAhgSZnIWtHWO7uaivturhPXxmnOZY5zI_45gd9hHzgrOaM68_7en8IqRZMiJqLmgF_Ra64AlU1DYjXJTPFKyYlXJK3Oe8ZY4syb8glaKVhCeqKzHfDlOwQW9vRdTcjvem3sQt_7BTiQH1M9CHmKY6YyssB6ebYj7sSHd2g_ZlpGOi0Q7pOsSQ7tPQBu0PIX-gq9qNNIZeW32Ha0R-uwxQLm-x4fEcuvO0yvn_e1-Tp-83j6rba3K_vVt82lQOlpwoBtsIJr0SjJfcLa7VVyvJWWoSldMx7sVwyBQAMwW81WCud1HyhpPbg4Jp8OveOKf6aMU-mD9lh19kB45yNaNSCc9loXlBxRl2KOSf0Zkyht-loODMn3WZvTrrNSbfhwhTd5ejjc_-87bF9OfnntwBfzwCWXx4CJpNdwMFhGxK6ybQx_K__LxRokoc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2758114761</pqid></control><display><type>article</type><title>Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Seyferth, Elisabeth R. ; Itkin, Maxim ; Nadolski, Gregory J.</creator><creatorcontrib>Seyferth, Elisabeth R. ; Itkin, Maxim ; Nadolski, Gregory J.</creatorcontrib><description>To compare the effectiveness of and adverse events related to intranodal glue embolization (IGE) with those of intracavitary sclerotherapy for the treatment of postoperative groin and pelvic lymphatic leaks.
From November 2015 to July 2021, IGE for postoperative pelvic or groin lymphocele or lymphorrhea was performed in 33 patients. From January 2010 to July 2021, 28 patients with postoperative pelvic or groin lymphocele were treated with sclerosis alone. Clinical success was defined as resolution of drainage within 3 weeks of the last intervention performed without recurrence. Patients presenting >1 year after surgery or with <30 days of follow-up were excluded. Patients with lymphorrhea treated with IGE were not statistically compared with those in the sclerosis group because they were not eligible for sclerosis.
Clinical success was similar between the groups (lymphocele IGE, 15/18, 83.3%, vs sclerosis, 15/23, 65.2% [P = .29]; lymphorrhea IGE, 8/9, 88.9%). The mean number of interventions performed to successfully treat a lymphocele was significantly higher in the sclerosis group (2.5 for sclerosis vs 1.3 for IGE; P = .003; lymphorrhea IGE, 1.0). The mean time to resolution was significantly longer for sclerosis than for IGE (27 vs 7 days; P = .002; 4 days for lymphorrhea IGE). There were no sclerosis-related adverse events and 2 IGE-related adverse events: (a) 1 case of mild lymphedema and (b) 1 case of nontarget embolization resulting in deep vein thrombosis.
For treatment of postoperative pelvic and groin lymphoceles, IGE results in faster resolution with fewer interventions compared with sclerosis. IGE is also an effective treatment for postoperative groin lymphorrhea.
[Display omitted]</description><identifier>ISSN: 1051-0443</identifier><identifier>EISSN: 1535-7732</identifier><identifier>DOI: 10.1016/j.jvir.2022.12.031</identifier><identifier>PMID: 36563935</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Groin ; Humans ; Immunoglobulin E ; Lymphatic Diseases - diagnostic imaging ; Lymphatic Diseases - etiology ; Lymphatic Diseases - therapy ; Lymphocele - diagnostic imaging ; Lymphocele - etiology ; Lymphocele - therapy ; Pelvis ; Postoperative Complications - diagnostic imaging ; Postoperative Complications - etiology ; Postoperative Complications - therapy ; Sclerotherapy - adverse effects ; Sclerotherapy - methods</subject><ispartof>Journal of vascular and interventional radiology, 2023-04, Vol.34 (4), p.600-606</ispartof><rights>2022 SIR</rights><rights>Copyright © 2022 SIR. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-e33b2c2f527641f8aa6a55a1d4ae394c0ff299053330e3fb63aa4c4618546f3c3</citedby><cites>FETCH-LOGICAL-c356t-e33b2c2f527641f8aa6a55a1d4ae394c0ff299053330e3fb63aa4c4618546f3c3</cites><orcidid>0000-0003-1361-7109 ; 0000-0001-6937-157X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jvir.2022.12.031$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36563935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Seyferth, Elisabeth R.</creatorcontrib><creatorcontrib>Itkin, Maxim</creatorcontrib><creatorcontrib>Nadolski, Gregory J.</creatorcontrib><title>Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy</title><title>Journal of vascular and interventional radiology</title><addtitle>J Vasc Interv Radiol</addtitle><description>To compare the effectiveness of and adverse events related to intranodal glue embolization (IGE) with those of intracavitary sclerotherapy for the treatment of postoperative groin and pelvic lymphatic leaks.
From November 2015 to July 2021, IGE for postoperative pelvic or groin lymphocele or lymphorrhea was performed in 33 patients. From January 2010 to July 2021, 28 patients with postoperative pelvic or groin lymphocele were treated with sclerosis alone. Clinical success was defined as resolution of drainage within 3 weeks of the last intervention performed without recurrence. Patients presenting >1 year after surgery or with <30 days of follow-up were excluded. Patients with lymphorrhea treated with IGE were not statistically compared with those in the sclerosis group because they were not eligible for sclerosis.
Clinical success was similar between the groups (lymphocele IGE, 15/18, 83.3%, vs sclerosis, 15/23, 65.2% [P = .29]; lymphorrhea IGE, 8/9, 88.9%). The mean number of interventions performed to successfully treat a lymphocele was significantly higher in the sclerosis group (2.5 for sclerosis vs 1.3 for IGE; P = .003; lymphorrhea IGE, 1.0). The mean time to resolution was significantly longer for sclerosis than for IGE (27 vs 7 days; P = .002; 4 days for lymphorrhea IGE). There were no sclerosis-related adverse events and 2 IGE-related adverse events: (a) 1 case of mild lymphedema and (b) 1 case of nontarget embolization resulting in deep vein thrombosis.
For treatment of postoperative pelvic and groin lymphoceles, IGE results in faster resolution with fewer interventions compared with sclerosis. IGE is also an effective treatment for postoperative groin lymphorrhea.
[Display omitted]</description><subject>Groin</subject><subject>Humans</subject><subject>Immunoglobulin E</subject><subject>Lymphatic Diseases - diagnostic imaging</subject><subject>Lymphatic Diseases - etiology</subject><subject>Lymphatic Diseases - therapy</subject><subject>Lymphocele - diagnostic imaging</subject><subject>Lymphocele - etiology</subject><subject>Lymphocele - therapy</subject><subject>Pelvis</subject><subject>Postoperative Complications - diagnostic imaging</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - therapy</subject><subject>Sclerotherapy - adverse effects</subject><subject>Sclerotherapy - methods</subject><issn>1051-0443</issn><issn>1535-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFqGzEQhkVpaNK0L9BD0bGX3UoaSWuXXopJnYAhgSZnIWtHWO7uaivturhPXxmnOZY5zI_45gd9hHzgrOaM68_7en8IqRZMiJqLmgF_Ra64AlU1DYjXJTPFKyYlXJK3Oe8ZY4syb8glaKVhCeqKzHfDlOwQW9vRdTcjvem3sQt_7BTiQH1M9CHmKY6YyssB6ebYj7sSHd2g_ZlpGOi0Q7pOsSQ7tPQBu0PIX-gq9qNNIZeW32Ha0R-uwxQLm-x4fEcuvO0yvn_e1-Tp-83j6rba3K_vVt82lQOlpwoBtsIJr0SjJfcLa7VVyvJWWoSldMx7sVwyBQAMwW81WCud1HyhpPbg4Jp8OveOKf6aMU-mD9lh19kB45yNaNSCc9loXlBxRl2KOSf0Zkyht-loODMn3WZvTrrNSbfhwhTd5ejjc_-87bF9OfnntwBfzwCWXx4CJpNdwMFhGxK6ybQx_K__LxRokoc</recordid><startdate>202304</startdate><enddate>202304</enddate><creator>Seyferth, Elisabeth R.</creator><creator>Itkin, Maxim</creator><creator>Nadolski, Gregory J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1361-7109</orcidid><orcidid>https://orcid.org/0000-0001-6937-157X</orcidid></search><sort><creationdate>202304</creationdate><title>Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy</title><author>Seyferth, Elisabeth R. ; Itkin, Maxim ; Nadolski, Gregory J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-e33b2c2f527641f8aa6a55a1d4ae394c0ff299053330e3fb63aa4c4618546f3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Groin</topic><topic>Humans</topic><topic>Immunoglobulin E</topic><topic>Lymphatic Diseases - diagnostic imaging</topic><topic>Lymphatic Diseases - etiology</topic><topic>Lymphatic Diseases - therapy</topic><topic>Lymphocele - diagnostic imaging</topic><topic>Lymphocele - etiology</topic><topic>Lymphocele - therapy</topic><topic>Pelvis</topic><topic>Postoperative Complications - diagnostic imaging</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - therapy</topic><topic>Sclerotherapy - adverse effects</topic><topic>Sclerotherapy - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Seyferth, Elisabeth R.</creatorcontrib><creatorcontrib>Itkin, Maxim</creatorcontrib><creatorcontrib>Nadolski, Gregory J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Seyferth, Elisabeth R.</au><au>Itkin, Maxim</au><au>Nadolski, Gregory J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy</atitle><jtitle>Journal of vascular and interventional radiology</jtitle><addtitle>J Vasc Interv Radiol</addtitle><date>2023-04</date><risdate>2023</risdate><volume>34</volume><issue>4</issue><spage>600</spage><epage>606</epage><pages>600-606</pages><issn>1051-0443</issn><eissn>1535-7732</eissn><abstract>To compare the effectiveness of and adverse events related to intranodal glue embolization (IGE) with those of intracavitary sclerotherapy for the treatment of postoperative groin and pelvic lymphatic leaks.
From November 2015 to July 2021, IGE for postoperative pelvic or groin lymphocele or lymphorrhea was performed in 33 patients. From January 2010 to July 2021, 28 patients with postoperative pelvic or groin lymphocele were treated with sclerosis alone. Clinical success was defined as resolution of drainage within 3 weeks of the last intervention performed without recurrence. Patients presenting >1 year after surgery or with <30 days of follow-up were excluded. Patients with lymphorrhea treated with IGE were not statistically compared with those in the sclerosis group because they were not eligible for sclerosis.
Clinical success was similar between the groups (lymphocele IGE, 15/18, 83.3%, vs sclerosis, 15/23, 65.2% [P = .29]; lymphorrhea IGE, 8/9, 88.9%). The mean number of interventions performed to successfully treat a lymphocele was significantly higher in the sclerosis group (2.5 for sclerosis vs 1.3 for IGE; P = .003; lymphorrhea IGE, 1.0). The mean time to resolution was significantly longer for sclerosis than for IGE (27 vs 7 days; P = .002; 4 days for lymphorrhea IGE). There were no sclerosis-related adverse events and 2 IGE-related adverse events: (a) 1 case of mild lymphedema and (b) 1 case of nontarget embolization resulting in deep vein thrombosis.
For treatment of postoperative pelvic and groin lymphoceles, IGE results in faster resolution with fewer interventions compared with sclerosis. IGE is also an effective treatment for postoperative groin lymphorrhea.
[Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36563935</pmid><doi>10.1016/j.jvir.2022.12.031</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-1361-7109</orcidid><orcidid>https://orcid.org/0000-0001-6937-157X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1051-0443 |
| ispartof | Journal of vascular and interventional radiology, 2023-04, Vol.34 (4), p.600-606 |
| issn | 1051-0443 1535-7732 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2758114761 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Groin Humans Immunoglobulin E Lymphatic Diseases - diagnostic imaging Lymphatic Diseases - etiology Lymphatic Diseases - therapy Lymphocele - diagnostic imaging Lymphocele - etiology Lymphocele - therapy Pelvis Postoperative Complications - diagnostic imaging Postoperative Complications - etiology Postoperative Complications - therapy Sclerotherapy - adverse effects Sclerotherapy - methods |
| title | Intranodal Glue Embolization for Postoperative Lymphatic Leaks in the Groin and Pelvis: Comparison with Sclerotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T03%3A14%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intranodal%20Glue%20Embolization%20for%20Postoperative%20Lymphatic%20Leaks%20in%20the%20Groin%20and%20Pelvis:%20Comparison%20with%20Sclerotherapy&rft.jtitle=Journal%20of%20vascular%20and%20interventional%20radiology&rft.au=Seyferth,%20Elisabeth%20R.&rft.date=2023-04&rft.volume=34&rft.issue=4&rft.spage=600&rft.epage=606&rft.pages=600-606&rft.issn=1051-0443&rft.eissn=1535-7732&rft_id=info:doi/10.1016/j.jvir.2022.12.031&rft_dat=%3Cproquest_cross%3E2758114761%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2758114761&rft_id=info:pmid/36563935&rft_els_id=S105104432201435X&rfr_iscdi=true |